NYSE
$1,277.00▲ 0.25%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.20TShares out 9.400M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
38- 4d agoAfter-hours26.10.21 05:364Ownership#●●●
ELI LILLY & Co
Gabrielle Sulzberger, an insider at Eli Lilly & Co, reported changes in beneficial ownership of securities as of October 19, 2026. This filing serves as a standard disclosure of equity transactions by a corporate insider via Form 4.…more
$1,277.00+0.25%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoAfter-hours26.10.21 05:354Ownership
ELI LILLY & Co
Insider Juan R. Luciano of Eli Lilly & Co reported a change in beneficial ownership of securities effective October 19, 2026. This filing serves as a standard Form 4 disclosure regarding insider stock transactions.…more
$1,277.00+0.25%vs prev closeView filingShare - 4d agoAfter-hours26.10.21 05:344Ownership
ELI LILLY & Co
Eli Lilly & Co insider J. Erik Fyrwald filed a Form 4 report regarding changes in beneficial ownership of securities as of October 19, 2026. This filing serves as an official disclosure of the insider's equity position changes.…more
$1,277.00+0.25%vs prev closeView filingShare
37 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoPre-market26.10.23 20:01#●●●#●●●
GLP-1 Drug Adoption Reshapes US Consumer Habits and Retail Landscape
More than half of U.S. GLP-1 users now take the medication for weight management, driving significant shifts in dietary habits and discretionary spending. This structural change is forcing food manufacturers and apparel retailers to adapt their product offerings and shelf strategies.…more
$1,277.00+0.25%vs prev closeShareBenzinga
- 3d agoRegular26.10.22 23:41
●●●●●●●● ●●●●● ●●●●●●
Eli Lilly has begun construction on a $5 billion integrated manufacturing facility in Virginia to expand its U.S. production capabilities. This site will be the company's first to produce both active pharmaceutical ingredients and finished medicines in a single location.…more
$1,277.00+0.25%vs prev closeShareBenzinga - 5d agoRegular26.10.20 02:53
●●●●●●●● ●●●●● ●●●●●●
Roche has suspended all future investment decisions in Germany due to government-mandated drug price cuts. Simultaneously, the company announced a major collaboration with Hansoh Pharmaceutical for ADC drug development.…more
$1,277.00+0.25%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report